LAWRENCE KWONG to Colorectal Neoplasms
This is a "connection" page, showing publications LAWRENCE KWONG has written about Colorectal Neoplasms.
Connection Strength
0.856
-
Same Name, Different Game: EGFR Drives Intrinsic KRASG12C Inhibitor Resistance in Colorectal Cancer. Cancer Discov. 2020 08; 10(8):1094-1096.
Score: 0.253
-
The path to metastatic mouse models of colorectal cancer. Oncogene. 2018 05; 37(19):2481-2489.
Score: 0.214
-
APC and its modifiers in colon cancer. Adv Exp Med Biol. 2009; 656:85-106.
Score: 0.113
-
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Res. 2022 Sep 16; 82(18):3335-3344.
Score: 0.073
-
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
Score: 0.067
-
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes Dev. 2017 02 15; 31(4):370-382.
Score: 0.050
-
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Oncotarget. 2016 Jun 28; 7(26):39595-39608.
Score: 0.048
-
Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18. Genetics. 2007 Jun; 176(2):1237-44.
Score: 0.025
-
Accurate quantification of PGE2 in the polyposis in rat colon (Pirc) model by surrogate analyte-based UPLC-MS/MS. J Pharm Biomed Anal. 2018 Jan 30; 148:42-50.
Score: 0.013